Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125415012 | 12541501 | 2 | F | 201606 | 20160721 | 20160708 | 20160728 | EXP | NL-AMGEN-NLDSL2016087074 | AMGEN | 66.00 | YR | E | M | Y | 0.00000 | 20160728 | CN | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125415012 | 12541501 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 500 MUG (500MCG/ML 1,0ML), Q3WK | U | 103951 | 500 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | Q3W |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125415012 | 12541501 | 1 | Anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125415012 | 12541501 | HO |
| 125415012 | 12541501 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125415012 | 12541501 | Anaemia | |
| 125415012 | 12541501 | Decreased appetite | |
| 125415012 | 12541501 | Fatigue | |
| 125415012 | 12541501 | Leukopenia | |
| 125415012 | 12541501 | Pneumonia | |
| 125415012 | 12541501 | Terminal state |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |